Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 13

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 13
---
 of Arrangement” means the certificate giving effect to the Arrangement issued         
 by the Enterprise Registrar in accordance with the QBCA in respect of the Articles of Arrangement; |

- 3 -

| (v) | “Change of Recommendation” has the meaning set out in Section 8.2(a)(iii)(A); |

| (w) | “Circular” means the information circular and proxy statement to be prepared and sent to the       
 Shareholders as is required pursuant to the Interim Order and Laws in connection with the Meeting. |

| (x) | “Closing Cash Calculation” means the Company’s good faith, estimated calculation of    
 Closing Net Cash as of the Cash Determination Time determined in accordance with GAAP; |

| (y) | “Closing Cash Schedule” has the meaning ascribed to it in Section 2.8(a); |

| (z) | “Closing Net Cash” means an amount, without duplication, equal to (i) the                                                                                                                                                                    
 Company’s cash, cash equivalents and marketable securities (which shall include deposits in transit and be net of outstanding checks and drafts and further expressly exclude Restricted Cash), minus (ii) all Closing Transaction           
 Expenses, minus (iii) all Liabilities (net of any refundable deposits not otherwise payable under the CVR Agreement), minus (iv) lease termination fees or liabilities for future lease payments (if applicable) (net of any                 
 deposits, pre-paid rent or other payments made in advance to the applicable landlords under such leases not otherwise payable under the CVR Agreement), minus (v) $4,000,000, minus (vi) any unpaid                                          
 Taxes (if any) of the Company and the Subsidiary for Tax periods (or portions thereof) ending on or before the Effective Date, minus (vii) the employer portion of all Taxes payable on the aggregate Cash Amount payable in accordance with 
 the Plan of Arrangement, minus (viii) any Taxes required to be withheld from a payment by or on behalf of the Company, for the avoidance of doubt, other than the Distribution, as a result of the Contemplated Transactions (as reasonably  
 determined by Purchaser in consultation with the Company’s tax and legal advisors);                                                                                                                                                          |

| (aa) | “Closing Transaction Expenses” means the amount equal to the sum (without duplication) of:                                                                                                                                                              
 (i) any fees and expenses incurred by the Company in connection with (A) obtaining waivers, consents or approvals of any Governmental Entity or other